Literature DB >> 28879186

Bullying and Quality of Life in Pediatric Alopecia Areata.

Theresa Christensen1, Jessica S Yang2, Leslie Castelo-Soccio3,4.   

Abstract

Alopecia areata (AA) is a clinically heterogeneous disease that is characterized by nonscarring hair loss, nail changes, and increased risk of other autoimmune disease. During clinical visits, children with AA often report bullying. We report survey results that highlight the prevalence of bullying and surrounding emotional impact of AA in pediatric patients. We found that bullying was common overall and additional psychological impact, including impairment of social and home life, was even more common. Children of all ages experienced bullying. Boys reported increased physical bullying. Interestingly, those with more severe disease and longer duration of disease experienced less bullying than those with less severe disease.

Entities:  

Keywords:  Alopecia areata; Bullying; Quality of life

Year:  2017        PMID: 28879186      PMCID: PMC5582476          DOI: 10.1159/000466704

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  6 in total

1.  Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation.

Authors:  E Olsen; M Hordinsky; S McDonald-Hull; V Price; J Roberts; J Shapiro; K Stenn
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

2.  A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases.

Authors:  P E Beattie; M S Lewis-Jones
Journal:  Br J Dermatol       Date:  2006-07       Impact factor: 9.302

Review 3.  Diagnosis and management of alopecia in children.

Authors:  Leslie Castelo-Soccio
Journal:  Pediatr Clin North Am       Date:  2014-01-21       Impact factor: 3.278

4.  Social and psychological implications of alopecia areata.

Authors:  H O Beard
Journal:  J Am Acad Dermatol       Date:  1986-04       Impact factor: 11.527

5.  Psychological status of patients with alopecia areata.

Authors:  Stefania Alfani; Valeria Antinone; Aurelia Mozzetta; Cristina Di Pietro; Cinzia Mazzanti; Piero Stella; Desanka Raskovich; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2012-05       Impact factor: 4.437

6.  Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data.

Authors:  Qiuling Shi; Madeleine Duvic; Joyce S Osei; Maria K Hordinsky; David A Norris; Vera H Price; Christopher I Amos; Angela M Christiano; Tito R Mendoza
Journal:  J Investig Dermatol Symp Proc       Date:  2013-12
  6 in total
  4 in total

Review 1.  Treatment of pediatric alopecia areata: A systematic review.

Authors:  Virginia R Barton; Atrin Toussi; Smita Awasthi; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2021-04-30       Impact factor: 15.487

2.  A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.

Authors:  Jake Macey; Helen Kitchen; Natalie V J Aldhouse; Emily Edson-Heredia; Russel Burge; Apurva Prakash; Brett A King; Natasha Mesinkovska
Journal:  Br J Dermatol       Date:  2022-02-25       Impact factor: 11.113

Review 3.  An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.

Authors:  Maddison Lensing; Ali Jabbari
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

4.  The psychologic impact of loose anagen syndrome and short anagen syndrome.

Authors:  Michael J Randolph; Eran C Gwillim; Betty Nguyen; Antonella Tosti
Journal:  Pediatr Dermatol       Date:  2022-04-16       Impact factor: 1.997

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.